Ms. Rougier-Chapman is a strategic leader with deep domain expertise spanning the diagnostics, genomics and life science sectors. Over the past two decades, she has been delivering successful business growth for large multinational and rapidly scaling companies through commercialization of genomic solutions for clinical and research use. As Head of Labcorp Oncology Marketing, she is responsible for expanding the Labcorp brand and revenues by leading go-to-market efforts including growth strategy, product marketing, thought leadership and marketing programs spanning oncology drug development and diagnostics. She recently joined Labcorp through the acquisition of PGDx where she was SVP, Head of Marketing & Commercial Strategy. Ms. Rougier-Chapman also held sales & marketing leadership roles at Invitae, ArcherDx, Bionano Genomics, Agilent Technologies, as well as various commercial roles at Advanced Cell Diagnostics, Cogenics, Incyte Genomics, and Stratagene. She holds an M.S. in Molecular Cancer Biology and a B.S. in Biology from Duke University.
Clinical Dx Showcase:
Personal Genome Diagnostics is empowering the fight against cancer by unlocking actionable information from the genome. We have developed an innovative and comprehensive portfolio of RUO and IVD tissue-based and non-invasive liquid biopsy genomic profiling solutions for use in laboratories worldwide.
LBx: Expanding Access to Precision Medicine with Innovations in Drug Dev. & Dx
Partner with PGDx from biomarker discovery to diagnosis and unlock the power of genomic data
The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative